Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at Leerink Partners
Leerink Partners started coverage on shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) in a report released on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $28.00 price target on the stock. Maze Therapeutics Price Performance Shares of NASDAQ:MAZE opened at $10.57 on Tuesday. Maze Therapeutics has a 52 week low of $10.08 […]
Leerink Partners started coverage on shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) in a report released on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $28.00 price target on the stock. Maze Therapeutics Price Performance Shares of NASDAQ:MAZE opened at $10.57 on Tuesday. Maze Therapeutics has a 52 week low of $10.08 […]
